Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)? (Q35030826)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)?	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492729%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)? (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492729%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

ascending cholangitis

0 references

primary biliary cholangitis

0 references

Javier P Gisbert

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492729%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

author name string

E A Jones

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492729%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

J M Pajares

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492729%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

R Moreno-Otero

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492729%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

language of work or name

0 references

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492729%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492729%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492729%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492729%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

17-27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12492729%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Chronic cholestatic diseases

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Immunopathogenesis of cholestatic autoimmune liver diseases

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Changes in titers of antimitochondrial and antinuclear antibodies during the course of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Molecular structure and hepatotoxicity: compared data about two closely related thiophene compounds

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Negative conversion of antimitochondrial antibody in primary biliary cirrhosis: a case of autoimmune cholangitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Autoimmune cholangitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Autoimmune cholangitis with good response to corticoids

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Autoimmune hepatitis and its variant syndromes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

The variant forms of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Autoimmune cholangitis within the spectrum of autoimmune liver disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: is autoimmune cholangitis an early stage of primary biliary cirrhosis?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

The pathology of primary biliary cirrhosis and autoimmune cholangitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

The ability of anti-carbonic anhydrase II antibody to distinguish autoimmune cholangitis from primary biliary cirrhosis in Japanese patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Treatment of autoimmune cholangitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

[Autoimmune cholangitis or autoimmune hepatitis with cholestatic component]

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Frequency and nature of the variant syndromes of autoimmune liver disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Three patients with autoimmune cholangiopathy treated with prednisolone

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Autoimmune disease overlaps and the liver: two for the price of one?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Autoimmune cholangitis with features of autoimmune hepatitis: successful treatment with immunosuppressive agents and ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01381.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35030826&oldid=1538212025"